國家衛生研究院 NHRI:Item 3990099045/14504

NHRI > National Institute of Cancer Research > Li-Tzong Chen > Conference Papers/Meeting Abstract > Item 3990099045/14504

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/14504

Title:	Toward collaboration among cancer trials groups in Asia: TCOG perspective
Authors:	Chen, LT
Contributors:	National Institute of Cancer Research
Abstract:	It has been well recognized that investigator-initiated academic clinical trials is an important component in developing practice-changing cancer treatment, for instances, FOLFIRINOX in metastatic and resectable pancreatic cancer and FLOT in locally advanced gastric cancer. Because of the difference in prevalent cancer types, pharmacogenomics, tumor biology and/or associated genetic alterations, and new drug approval/reimbursement, clinical practice pattern and subsequent patient outcomes between Eastern and Western populations, the role for such academic clinical intervention trials, including real-world data (RWD) collection registration trials, to investigate the safety and efficacy of repurposing or new agents for new indications evaluation is even more relevant in Asia. Facing the rapid advances in modern biotechnology and biomarker-enriched molecular targeted/immunotherapy, multi-national intergroup study is an attractive model to collect sufficient patients or data in a reasonable period of time for non-industry sponsored trials. Taiwan Cooperative Oncology Group (TCOG) is a government funding supported organization with extensive domestic, multicenter trial experience. However, international collaborative academic trials are much more challenging. From our previous experience, hurdles existed, such as, ethical and privacy protection issue of real world data sharing, funding and medication availability issues for intervention trials, translational tissue acquisition, storage and usage and NGS issue for biomarker-driven trials, etc. The real-world cases will be presented in the meeting!
Date:	2022-07
Relation:	Annals of Oncology. 2022 Jul;33(Suppl. 6):S449.
Link to:	http://dx.doi.org/10.1016/j.annonc.2022.05.491
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0923-7534&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000834940400107
Appears in Collections:	[Li-Tzong Chen] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000834940400107.pdf		109Kb	Adobe PDF	121	View/Open

Loading...